关注
Dennis Mujuni
Dennis Mujuni
Researcher
在 genlabsolutions.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Effectiveness of thermal screening in detection of COVID-19 among truck drivers at Mutukula Land Point of Entry, Uganda
A Nsawotebba, I Ibanda, I Ssewanyana, P Ogwok, F Ocen, C Okiira, ...
PloS one 16 (5), e0251150, 2021
202021
Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year’s review
D Mujuni, DL Kasemire, I Ibanda, J Kabugo, A Nsawotebba, JE Phelan, ...
BMC Infectious Diseases 22 (1), 363, 2022
102022
Implementation of GeneXpert MTB/Rif proficiency testing program: A Case of the Uganda national tuberculosis reference laboratory/supranational reference laboratory
J Kabugo, J Namutebi, D Mujuni, A Nsawotebba, GW Kasule, K Musisi, ...
Plos one 16 (5), e0251691, 2021
72021
Operationalization of COVID-19 Rapid Diagnosis Using Xpert® Xpress SARS CoV-2 Assay in Resource-Limited Settings: Early Implementation Lessons From Uganda
A Nsawotebba, I Ibanda, B Ssentalo Bagaya, A Nyombi, A Kagirita, ...
Research Square, 2021
22021
Advancing proficiency testing for ultra in resource-limited settings using dried tube specimen: A study by SRL-Uganda
J Kabugo, J Namutebi, I Adam, D Mujuni, D Tugumisirize, O Denis, ...
Plos one 18 (3), e0282650, 2023
12023
Beyond diagnostic connectivity: Leveraging digital health technology for the real-time collection and provision of high-quality actionable data on infectious diseases in Uganda
D Mujuni, J Tumwine, K Musisi, E Otim, MR Farhat, D Nabulobi, ...
PLOS Digital Health 3 (8), e0000566, 2024
2024
Impact of randomized blinded rechecking program on the performance of the AFB Microscopy Laboratory Network in Uganda: a decadal retrospective study
A Nsawotebba, I Ibanda, D Mujuni, S Nabadda, D Nadunga, J Kabugo, ...
BMC Infectious Diseases 23 (1), 494, 2023
2023
Second-line drug resistance markers as proxy indicators of time to sputum culture conversion among second-line drug resistant tuberculosis patients tested in Uganda: A cross …
D Mujuni, W Ssengooba, I Ibanda, JS Kabugo, DL Kasemire, E Nampewo, ...
F1000Research 12 (62), 62, 2023
2023
Second-line drug resistance markers as indicators of time to sputum culture conversion among selected mycobacterium tuberculosis clinical isolates at the Uganda National …
D Mujuni
2022
系统目前无法执行此操作,请稍后再试。
文章 1–9